Nicoya support researchers during COVID-19

Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, announced today that they will be offering Surface Plasmon Resonance (SPR) technical support to all researchers – at no cost – during COVID-19.

KITCHENER, Ontario–(BUSINESS WIRE)–#Biopharama–Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, announced today that they will be offering Surface Plasmon Resonance (SPR) technical support to all researchers – at no cost – during COVID-19.

The global impact of COVID-19 has made SARS-CoV-2 vaccine development a priority for researchers around the world. Finding a solution involves understanding the molecular characteristics of the virus through structural data, binding affinity and kinetics. SPR technology allows researchers to obtain this data in real-time and without the use of labels.

To help accelerate COVID-19 research and support the scientific community, Nicoya is offering SPR support for data analysis or experimental design at no cost. With this initiative, Nicoya aims to help researchers obtain high-quality binding kinetics data faster so they can better understand disease pathways, lead generation, and candidate validation. Researchers interested in requesting SPR support can do so at nicoyalife.com/covid-19-spr-support.

“Nicoya has a long history of standing behind scientists,” said Ryan Denomme, co-founder and CEO of Nicoya. “Now that this epidemic has brought their work to the forefront, it’s even more important that we do what we can to empower scientific research.”